Acetazolamide May Help COPD Patients Reach New Heights
Acetazolamide may prevent some patients with chronic obstructive pulmonary disease (COPD) from suffering altitude-related adverse health effects (ARAHE) when traveling, a randomized controlled trial showed. In patients with moderate to severe COPD traveling to and staying for 2 days at 3,100 m, ARAHE occurred in 50% of those taking acetazolamide compared with 74% of those […]
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF
BARCELONA — The addition of IV acetazolamide to loop diuretic therapy led to a greater incidence of successful early decongestion in patients with acute decompensated heart failure (HF), according to the ADVOR trial. The primary outcome of successful decongestion within 3 days after randomization was 42.2% with acetazolamide versus 30.5% with placebo (P<0.001), reported Wilfried […]